HomeKNE • CVE
add
Kane Biotech Inc
Previous close
$0.050
Day range
$0.045 - $0.055
Year range
$0.045 - $0.17
Market cap
9.12M CAD
Avg Volume
134.24K
P/E ratio
1.13
Dividend yield
-
Primary exchange
CVE
In the news
Financials
Income Statement
Revenue
Net income
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 412.51K | 695.04% |
Operating expense | 1.20M | -2.01% |
Net income | -1.22M | 12.70% |
Net profit margin | -295.38 | 89.02% |
Earnings per share | — | — |
EBITDA | -1.14M | -0.87% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 493.58K | -40.29% |
Total assets | 2.76M | -52.47% |
Total liabilities | 3.89M | -74.63% |
Total equity | -1.13M | — |
Shares outstanding | 165.77M | — |
Price to book | -5.00 | — |
Return on assets | -110.58% | — |
Return on capital | -393.12% | — |
Cash Flow
Net change in cash
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.22M | 12.70% |
Cash from operations | -1.10M | -12.14% |
Cash from investing | -44.83K | -103.73% |
Cash from financing | 1.28M | 419.99% |
Net change in cash | 134.77K | 172.90% |
Free cash flow | -869.45K | -242.80% |
About
Founded
2001
Headquarters
Website
